acetyl sulfisoxazole,
Sulfisoxazole acetyl,
80-74-0,
Lipo Gantrisin,
Acetylsulfisoxazole,
ACETYL SULFISOXAZOLE,
Sulfisoxazole acetal,
UNII-WBT5QH3KED,
N-((4-Aminophenyl)sulfonyl)-N-(3,4-dimethylisoxazol-5-yl)acetamide,
WBT5QH3KED,
EINECS 201-305-3,
Sulfisoxazole acetyl [USP],
N-(3,4-Dimethyl-5-isoxazolyl)-N-sulfanilylacetamide,
N-(4-aminophenyl)sulfonyl-N-(3,4-dimethyl-1,2-oxazol-5-yl)acetamide,
N-3,4-Dimethylisoxazol-5-yl-N-sulphanilylacetamide,
Sulfisoxazole acetyl (USP),
C14H16N2O4S,
N-(4-aminophenyl)sulfonyl-N-(3,4-dimethylisoxazol-5-yl)acetamide,
Acetamide, N-((4-aminophenyl)sulfonyl)-N-(3,4-dimethyl-5-isoxazolyl)-,
Acetamide, N-[(4-aminophenyl)sulfonyl]-N-(3,4-dimethyl-5-isoxazolyl)-,
acetylsulfafurazole,
Sulfisoxazole acetyl [USAN],
N-[(4-aminophenyl)sulfonyl]-N-(3,4-dimethylisoxazol-5-yl)acetamide,
Lipo gantrisin (TN),
Acetylsulfisoxazole (JAN),
DSSTox_CID_3620,
AC1Q6V7X,
DSSTox_RID_97551,
DSSTox_GSID_23620,
SCHEMBL41727,
AC1L1N11,
ZINC2114,
CHEMBL1200910,
DTXSID4023620,
CHEBI:135975,
JFNWFXVFBDDWCX-UHFFFAOYSA-N,
Tox21_113660,
MFCD00072139,
API0004283,
CAS-80-74-0,
KS-000001H6,
NCGC00249884-01,
AN-24034,
LS-177521,
B4954,
4-Dimethylisoxazol-5-yl-N-sulphanilylacetamide,
D05956,
Acetamide, N-(3,4-dimethyl-5-isoxazolyl)-N-sulfanilyl-,
N-Acetyl-4-amino-N-(3,4-dimethyl-5-isoxazolyl)benzenesulfonamide #,
N-[(4-aminophenyl)sulfonyl]-N-(3,4-dimethyl-5- isoxazolyl)acetamide,
Gantrisin,
Pediazole,
Mixture Name,
Gantrisin (TN),
GANTRISIN PEDIATRIC,
ERYZOLE,
ILOSONE SULFA,
SULFISOXAZOLEACETYL(200MG),
C13H15N3O4S,
CID6662,
AR-1H6487,
C13-H15-N3-O4-S,
SULFISOXAZOLE ACETYL (200 MG),
ERYTHROMYCIN ETHYLSUCCINATE AND SULFISOXAZOLE ACETYL,
Acetamide, N-[(4-aminophenyl)sulfonyl] -N-(3,4-dimethyl-5-isoxazolyl)-,
85233-29-0,